VLY-686

DRUG2 trials

Sponsors

Vanda Pharmaceuticals

Conditions

PruritusTreatment-resistant Pruritus Associated With Atopic Dermatitis

Phase 1

Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P

CompletedNCT01919944

Vanda PharmaceuticalsPruritus

Start: 2013-08-31End: 2013-11-30Updated: 2015-06-03

Phase 2

Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis

CompletedNCT02004041

Vanda PharmaceuticalsTreatment-resistant Pruritus Associated With Atopic Dermatitis

Start: 2013-12-10End: 2015-02-19Updated: 2024-06-11